BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2565518)

  • 1. Plasma endothelin levels in patients with uraemia.
    Koyama H; Tabata T; Nishzawa Y; Inoue T; Morii H; Yamaji T
    Lancet; 1989 May; 1(8645):991-2. PubMed ID: 2565518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive endothelin in uraemia: relationship with blood pressure.
    Totsune K; Takahashi K; Sone M; Murakami O; Yoshinaga K; Mouri T
    Nephrol Dial Transplant; 1992; 7(2):176-7. PubMed ID: 1314983
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma immunoreactive endothelin in uraemia.
    Webb DJ; Cockcroft JR
    Lancet; 1989 May; 1(8648):1211. PubMed ID: 2566777
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of dehydroascorbic acid in uraemic serum and the partial correction of dehydroascorbic acid deficiency by haemodialysis.
    Bakaev VV; Efremov AV; Tityaev II
    Nephrol Dial Transplant; 1999 Jun; 14(6):1472-4. PubMed ID: 10383010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between bioactivity and immunoreactivity of serum prolactin in uraemia.
    Mooradian AD; Morley JE; Korchik WP; Ma KW; Hartfel MA; Parsons JA
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):241-7. PubMed ID: 3978831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-3 concentrations in human plasma: the increased concentrations in patients undergoing haemodialysis.
    Suzuki N; Matsumoto H; Miyauchi T; Goto K; Masaki T; Tsuda M; Fujino M
    Biochem Biophys Res Commun; 1990 Jun; 169(2):809-15. PubMed ID: 2192712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII complex in uraemia and effects of haemodialysis.
    Turney JH; Woods HF; Fewell MR; Weston MJ
    Br Med J (Clin Res Ed); 1981 May; 282(6277):1653-6. PubMed ID: 6786417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of immunoreactive endothelin in plasma of hemodialysis patients.
    Totsune K; Mouri T; Takahashi K; Ohneda M; Sone M; Saito T; Yoshinaga K
    FEBS Lett; 1989 Jun; 249(2):239-42. PubMed ID: 2661264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal lipoprotein in uraemic patients treated conservatively and by maintenance haemodialysis.
    Alam SM; Bhatt AK
    J Assoc Physicians India; 1991 Feb; 39(2):170-1. PubMed ID: 1885478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin in chronic renal failure.
    Deray G; Carayon A; Maistre G; Benhmida M; Masson F; Barthelemy C; Petitclerc T; Jacobs C
    Nephrol Dial Transplant; 1992; 7(4):300-5. PubMed ID: 1317519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis.
    Remuzzi G; Livio M; Marchiaro G; Mecca G; de Gaetano G
    Nephron; 1978; 22(4-6):347-53. PubMed ID: 740096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of 125I-fibrinogen to blood platelets in patients with chronic uraemia.
    Komarnicki M; Zozulińska M; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):638-41. PubMed ID: 2448203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
    Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
    Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
    Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
    Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of uraemia-induced decrease in insulin binding on erythrocytes.
    Marttinen A; Pasternack A; Koivula T
    Nephrol Dial Transplant; 1987; 2(4):233-7. PubMed ID: 3118263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum methylmalonic acid in uraemia.
    Moelby L; Rasmussen K; Rasmussen HH
    Scand J Clin Lab Invest; 1992 Jun; 52(4):351-4. PubMed ID: 1439520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of beta-endorphin in uraemic patients during haemodialysis.
    Caruso U; Lezoche E; Mariani P; Elli M; Tisone G; Cravotto E; Casciani CU
    Int J Clin Pharmacol Res; 1988; 8(1):17-20. PubMed ID: 2966773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.